Uwe Perbandt

All filings by Uwe Perbandt on record concern Viromed Medical AG. In total, 26 filings cover trades dated from 6 June 2025 to 4 September 2026.

Both buying and selling appear: 10 purchases worth €215k, against 16 sales worth €7.6M. On balance, insiders were net sellers of €7.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 7 purchases and 5 sales.

Half of the purchases are above €12k and half below. Relative to company size, the median is 0.0086% of market cap (7 purchases with a known value). No cluster: in 10 purchases, no other insider of the company bought within 30 days.

On 8 September 2026 came the latest disclosure, an open-market purchase for €11k in Viromed Medical AG. Between a trade and the moment it shows up on BaFin, the median delay is 5 days. The regulation allows three business days to notify a trade (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by BaFin. They describe what insiders did and are not a recommendation.